Drugs / JS012
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05388279 | Apr → Sep 2022 | — | Shanghai Junshi Bioscience Co., Ltd. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JS012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05388279 ↗ |
| Route | Intravenous | “JS012, i.v., q3w” NCT05388279 ↗ |